A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease-Reference-Cited by-同舟云学术

A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease

Published:2011-10 Issue:4 Volume:162 Page:740-747
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Kufner Sebastian,de Waha Antoinette,Tomai Fabrizio,Park Seong-Wook,Lee Seung-Whan,Lim Do-Sun,Kim Moo Hyun,Galloe Anders M.,Maeng Michael,Briguori Carlo,Dibra Alban,Schömig Albert,Kastrati Adnan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement;Elezi;J Am Coll Cardiol,1998

2. Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark;Jensen;Am J Cardiol,2010

3. Barry A, Wilkinson I, Halford V, et al. A clinical study and the national service framework for diabetes. J Tissue Viability 2004;14:124, 126, 128, passim.

4. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial;Morice;JAMA,2006

5. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymer-coated paclitaxel-eluting stents for the treatment of stenosed native arteriovenous fistulas: Long-term results from the ELUDIA study;The Journal of Vascular Access;2023-06-21

2. Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy;Biomedicine & Pharmacotherapy;2022-04

3. Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention;J GERIATR CARDIOL;2018

4. Paclitaxel-eluting stents versus sirolimus-eluting stents in patients with diabetes mellitus undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials;Internal and Emergency Medicine;2016-09-08

5. Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease;Medicine;2016-07